Cargando…
Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers
BACKGROUND: The early detection of digestive cancers and precancerous diseases remains a significant challenge. This study aimed to investigate the performance of the blood methylated SEPT9 (mSEPT9) assay, and the combination of this assay with serum protein markers, in hospital-based opportunistic...
Autores principales: | Song, Lele, Chen, Yan, Gong, Yuan, Wan, Jun, Guo, Shaohua, Liu, Hongyi, Li, Yuemin, Zeng, Zhen, Lu, Yinying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745555/ https://www.ncbi.nlm.nih.gov/pubmed/33403008 http://dx.doi.org/10.1177/1758835920962966 |
Ejemplares similares
-
Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2021) -
Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer
por: Loomans-Kropp, Holli A., et al.
Publicado: (2022) -
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
por: Oussalah, Abderrahim, et al.
Publicado: (2018) -
The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
por: Song, Lele, et al.
Publicado: (2017) -
SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
por: Li, Baoliang, et al.
Publicado: (2020)